Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error with a Home link, replacing the previously loaded study content and related links. This indicates the page is currently inaccessible rather than showing study details.
    Difference
    16%
    Check dated 2026-09-23T00:20:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new page revision, v3.7.0, has been published, replacing the previous v3.6.6. This reflects an update to the page's revision history rather than a change to substantive content.
    Difference
    0.0%
    Check dated 2026-09-16T00:20:14.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision history on the page was updated with new August 2026 entries. A new Revision: v3.6.6 supersedes the previous Revision: v3.6.5.
    Difference
    0.1%
    Check dated 2026-09-01T19:44:05.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new publication citation by Leighl NB et al. was added to the Publications section. The citation describes a plain-language summary of subcutaneous versus intravenous amivantamab plus lazertinib in EGFR-mutated NSCLC and notes that it is online ahead of print.
    Difference
    0.0%
    Check dated 2026-08-25T19:47:04.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor update to the page's version metadata rather than any changes to study content.
    Difference
    0.0%
    Check dated 2026-08-11T22:13:04.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Two new update dates (2026-07-31 and 2026-07-30) were added and two earlier dates (2026-07-06 and 2026-07-02) were removed from the study's record history, reflecting maintenance of the listing's update chronology.
    Difference
    0.1%
    Check dated 2026-08-04T23:26:32.000Z thumbnail image

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.